ConductScience.org, home

Paper3136117

Potentiation of antitumor activity of macrophages by recombinant interferon alpha A/D contained in gelatin microspheres.

Tabata Y and 3 others. Jpn J Cancer Res, 1988. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. Potentiation of antitumor activity of macrophages by recombinant interferon alpha A/D contained in gelatin microspheres. Papers, record 3136117. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3136117

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Potentiation of antitumor activity of macrophages by recombinant interferon alpha A/D contained in gelatin microspheres.
PubMed
Journal
Jpn J Cancer Res
PubMed
Year
1988
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
1.02
iCite
Revised in PubMed
2023-11-12
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tabata YY
2Uno KK
3Ikada YY
4Muramatsu SS

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Interferon Type IMajor topic
MacrophagesMajor topic
Animals
Female
Gelatin
Mice
Mice, Inbred BALB C
Mice, Inbred C3H
Microscopy, Electron
Microspheres
Phagocytosis
Recombinant Proteins
Species Specificity

Source PubMed

Download CSV of topics

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13921232Efficient activation of human blood monocytes to a tumoricidal state by liposomes containing human recombinant gamma interferon.Cancer Immunol Immunother1985https://conductscience.org/library/papers/3921232PubMed
22410097Treatment regimen and host T-cell-dependent therapeutic effect of interferon in mouse solid tumors.Cancer Res1985https://conductscience.org/library/papers/2410097PubMed
36158375Augmentation of human monocyte-mediated cytolysis by interferon.Cell Immunol1980https://conductscience.org/library/papers/6158375PubMed
47365733Tumor cytotoxicity of rat alveolar macrophages activated in vitro by endotoxin.J Reticuloendothel Soc1980https://conductscience.org/library/papers/7365733PubMed
5204610Recognition and destruction of target cells by tumoricidal macrophages.Isr J Med Sci1978https://conductscience.org/library/papers/204610PubMed
680335Ontogeny of macrophage function. I. Phagocytic activity and A-cell activity of newborn and adult mouse peritoneal macrophages.Dev Comp Immunol1978https://conductscience.org/library/papers/80335PubMed
74473563Discrimination between neoplastic and non-neoplastic cells in vitro by activated macrophages.J Natl Cancer Inst1974https://conductscience.org/library/papers/4473563PubMed
8568163Macrophage stimulation by bacterial lipopolysaccharides. I. Cytolytic effect on tumor target cells.J Exp Med1978https://conductscience.org/library/papers/568163PubMed
91180867Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids.Biken J1975https://conductscience.org/library/papers/1180867PubMed
103841037Antitumor and antimetastatic activities of human recombinant interferon alpha A/D.Clin Exp Metastasis1985https://conductscience.org/library/papers/3841037PubMed
112890735Macrophage activation through phagocytosis of muramyl dipeptide encapsulated in gelatin microspheres.J Pharm Pharmacol1987https://conductscience.org/library/papers/2890735PubMed
121092874Interaction of BCG-activated macrophages with neoplastic and nonneoplastic cell lines in vitro : quantitation of the cytotoxic reaction by release of tritiated thymidine from prelabeled target cells.J Natl Cancer Inst1975https://conductscience.org/library/papers/1092874PubMed
134606813Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives.Biochem Biophys Res Commun1974https://conductscience.org/library/papers/4606813PubMed
147430249Fibronectin-mediated uptake of gelatin-coated latex particles by peritoneal macrophages.J Cell Biol1980https://conductscience.org/library/papers/7430249PubMed
154813256Microencapsulation of a waxy solid: wall thickness and surface appearance studies.J Pharm Sci1974https://conductscience.org/library/papers/4813256PubMed
164553694Mechanism of immunologically specific killing of tumour cells by macrophages.Nature1972https://conductscience.org/library/papers/4553694PubMed
175383986Intravascular retention, dispersal, excretion and break-down of gelatin plasma substitutes.Bibl Haematol1969https://conductscience.org/library/papers/5383986PubMed
183871818Direct evidence for the role of LGL in the inhibition of experimental tumor metastases.J Immunol1985https://conductscience.org/library/papers/3871818PubMed
193923117Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages.J Immunol1985https://conductscience.org/library/papers/3923117PubMed
206480158
Inhibition of experimentally-induced murine metastases by recombinant alpha interferon: correlation between the modulatory effect of interferon treatment on natural killer cell activity and inhibition of metastases.
Int J Cancer1984https://conductscience.org/library/papers/6480158PubMed

See all 30 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
22194039Clinical trial of cisplatin-conjugated gelatin microspheres for patients with hepatocellular carcinoma.Jpn J Radiol2012https://conductscience.org/library/papers/22194039PubMed
17923785Degradable gelatin microspheres as an embolic agent: an experimental study in a rabbit renal model.Korean J Radiol2007https://conductscience.org/library/papers/17923785PubMed
2501256In vivo effects of recombinant interferon alpha A/D incorporated in gelatin microspheres on murine tumor cell growth.Jpn J Cancer Res1989https://conductscience.org/library/papers/2501256PubMed
2473465Synthesis of gelatin microspheres containing interferon.Pharm Res1989https://conductscience.org/library/papers/2473465PubMed
1996352Mononuclear phagocytes: a major population of effector cells responsible for rejection of allografted tumor cells in mice.Proc Natl Acad Sci U S A1991https://conductscience.org/library/papers/1996352PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IFNA13439PubTator's text mininghttps://conductscience.org/library/genes/3439NCBI Gene
IFNA23440PubTator's text mininghttps://conductscience.org/library/genes/3440NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3136117

GET https://conductscience.org/api/papers/v1/3136117/references?page=2